Search clinical trials for: GnrH agonist

Total 14598 results

Mayo Clinic

Recruiting

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment Prostate Cancer

Prostate Adenocarcinoma | Oligometastatic Prostate Carcinoma

United States
Mỹ Đức Hospital

Recruiting

Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients (FET-ADE)

Adenomyosis | Frozen Embryo Transfer | IVF

Vietnam
National Taiwan University Hospital
Debiopharm International SA; Ministry of Health and Welfare

Not yet recruiting

Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients (ESCALATE)

Triple Negative Breast Cancer | Premenopausal Breast Cancer
University of Washington
Breast Cancer Research Foundation

Not yet recruiting

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | Locally Advanced Unresectable Hormone Receptor-Positive...

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles (SOLOAGO)

In Vitro Fertilization | ICSI Intracytoplasmic Spermatozoid Injection

France
Embryolab Fertility Clinic
ART Fertility Clinics LLC

Recruiting

The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger

Ovarian Stimulation | Oocyte Donors | Human Chorionic Gonadotropin

Greece
Azienda Ospedaliero-Universitaria di Modena
University of Modena and Reggio Emilia; Ministero della Salute, Italy

Recruiting

Adenomyosis and ART (ADENOFERT)

Adenomyosis

Italy
Shaare Zedek Medical Center

Recruiting

Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates

Luteal Phase Support

Israel
Dana-Farber Cancer Institute
Pfizer; Prostate Cancer Foundation; Myovant Sciences GmbH

Recruiting

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

Prostatic Neoplasms | Prostate Cancer

United States
National Taiwan University Hospital

Recruiting

Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC

Metastatic Breast Cancer | Premenopausal Breast Cancer | ER Positive Breast Cancer

Taiwan
University of Colorado, Denver

Recruiting

Contributions to Hypertension With Androgen Deprivation Therapy (ARCH)

Hypertension | Prostate Cancer | Autonomic Dysfunction | Androgen Deprivation Therapy | Renal Disease

United States
National Institute of Arthritis and Musculoskeletal...

Recruiting

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Systemic Lupus Erythematosus (Sle) | Primary Ovarian Insufficiency (Poi)

United States
CRG UZ Brussel

Recruiting

Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone (LadyDe)

Oocyte Donation | Oocyte Donors

Belgium
University Medical Center Groningen
Radboud University Medical Center

Recruiting

A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease (AGAINST-PLD)

Autosomal Dominant Polycystic Kidney | Polycystic Liver Disease

Netherlands
Fudan University
Peking Union Medical College Hospital

Recruiting

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

Endometrial Neoplasm Malignant Stage I

China
Assaf-Harofeh Medical Center

Recruiting

Follicular Challenge Test to Predict Response to GnRH Agonist Triggering

Infertility, Female

Israel
Assaf-Harofeh Medical Center

Recruiting

Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

Ovarian Hyperstimulation Syndrome | Miscarriage | Pregnancy Early

Israel
University Hospital, Lille

Recruiting

The Therapy of Large Endometrioma (ENDOKYSTE)

Endometrioma | Endometriosis Ovary

France
Washington University School of Medicine
Merck Sharp & Dohme LLC; Good Ventures Foundation

Recruiting

Sleep Trial to Prevent Alzheimer's Disease (SToP-AD)

Sleep | Alzheimer Disease

United States
Universitair Ziekenhuis Brussel
Universitaire Ziekenhuizen KU Leuven

Recruiting

DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation (Depo-Trigger)

Breast Cancer Female

Belgium
Hopital Foch

Recruiting

Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis (DECATEC)

Endometriosis | Adenomyosis | Infertility, Female

France
Boston Children's Hospital
Children's Hospital Medical Center, Cincinnati

Recruiting

Skeletal Health and Bone Marrow Composition Among Youth

Puberty | Gender Dysphoria in Children | Bone Development

United States
Reproductive & Genetic Hospital of CITIC-Xiangya

Recruiting

Recombinant LH Supplementation Timing Strategies (From Day 1 or Day 6) to a Standard GnRH Agonist Long Protocol in Subsequent COS Cycle of Older Patients With Unexpected Poor or Suboptimal Ovarian Response

Infertility,Female

China
Moustafa Mohammed Abouelea

Recruiting

Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial

Effect of Adding GnRHa as Luteal Phase Support in Antagonist ART Cycles

Egypt
The University of Hong Kong

Recruiting

GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET

Subfertility

China
Dana-Farber Cancer Institute
Bayer; Decipher Biosciences

Recruiting

INTREPId (INTermediate Risk Erection PreservatIon Trial)

Prostate Cancer

United States
West China Second University Hospital

Recruiting

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

Atypical Endometrial Hyperplasia | Endometrial Cancer

China
Northwestern University

Recruiting

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Metastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Refractory Prostate Cancer | Castration-Resistant Prostatic Cancer

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Recruiting

Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

Stage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma

United States
Erasme University Hospital
Queen Fabiola Children's University Hospital

Recruiting

AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE) (CHANCE)

Lymphoma | Fertility Preservation | Pediatrics Cancer | Gonadotropin-releasing Hormone Agonist

France, Belgium
National Institute of Mental Health (NIMH)

Recruiting

The Role of Hormones in Postpartum Mood Disorders

Postpartum Depression

United States
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute

Active, not recruiting

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

Prostate Cancer

United States
Dana-Farber Cancer Institute
Janssen Scientific Affairs, LLC

Terminated

Conventional ADT w/ or w/Out Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT

Prostate Cancer

United States
McGill University Health Centre/Research Institute...

Withdrawn

Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids (eTAPE)

Endometriosis | Fibroids

Canada
Aragon Pharmaceuticals, Inc.

Active, not recruiting

An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

Prostatic Neoplasms

United States, France, Poland, Taiwan, Ukraine, United Kingdom, China, Belgium, Germany, Spain, Israel, Mexico, Malaysia, Romania, Turkey, Canada, Netherlands, Korea, Republic of, Brazil, Russian Federation, Argentina, Sweden, Czechia
Janssen Pharmaceutical K.K.

Active, not recruiting

A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma (YATAGARASU)

Salivary Gland Neoplasms

Japan
Ferring Pharmaceuticals

Completed

Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND) (BEYOND)

Infertility, Female

Norway, Israel, Denmark, Netherlands, Italy, Austria, Switzerland
European Organisation for Research and Treatment...

Active, not recruiting

Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer (PEGASUS)

Prostate Cancer

Germany, Spain, France, Belgium, United Kingdom, Switzerland, Italy, Denmark
Sidney Kimmel Cancer Center at Thomas Jefferson...
Sanofi

Completed

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

Prostate Cancer | Advanced Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
Chinese University of Hong Kong
Ipsen

Completed

Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Active, not recruiting

Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study) (READT)

Prostate Cancer

Hong Kong
Seattle Institute for Biomedical and Clinical Research
United States Department of Defense; University of Washington

Active, not recruiting

Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia

Metastatic Prostate Cancer | Androgen Deprivation Therapy

United States
Tanta University

Completed

Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve

Infertility | Intracytoplasmic Sperm Injection | Ovarian Reserve | GnRH Agonist

Egypt
Damascus University

Completed

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI

Polycystic Ovary Syndrome | Infertility | In Vitro Fertilization | Intracytoplasmic Sperm Injection

Syrian Arab Republic
Damascus University

Completed

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

Polycystic Ovary Syndrome | Infertility | In Vitro Fertilization | Intracytoplasmic Sperm Injection

Syrian Arab Republic
Damascus University

Completed

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI

Infertility | In Vitro Fertilization | Intracytoplasmic Sperm Injection

Syrian Arab Republic
Damascus University

Completed

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.

Infertility | In Vitro Fertilization | Intracytoplasmic Sperm Injection

Syrian Arab Republic
Belgian Study Group for Pediatric Endocrinology

Active, not recruiting

A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height (ZomaTrip)

Idiopathic Short Stature

Belgium
American University of Beirut Medical Center

Completed

The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies

Infertility | Sterility

Lebanon

Search clinical trials for: GnrH agonist

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations